MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Postoperative delirium after deep brain stimulation surgery for Parkinson’s disease

    F. Sasaki, G. Oyama, M. Ito, S. Sekimoto, R. Nakamura, T. Jo, Y. Simo, A. Umemura, N. Hattori (Tokyo, Japan)

    Objective: To investigate the potential predictive factors of postoperative delirium after deep brain stimulation surgery for Parkinson’s disease (PD). Background: Subthalamic nucleus deep brain stimulation…
  • 2017 International Congress

    Factors determining the motor outcome of STN DBS in PD patients: Evidence for Dual Actions

    C. Lee, E.J. Choi, S.-C. Park, J.K. Lee (Seoul, Republic of Korea)

    Objective: We investigated factors determining the motor outcome of STN DBS in patients with Parkinson disease (PD). Background: The STN DBS has revolutionized the management…
  • 2017 International Congress

    Effects of subthalamic and nigral stimulation on gait kinematics in Parkinson’s disease

    M. Scholten, J. Klemt, C. Plewnia, B. Bloem, F. Bunjes, R. Krüger, A. Gharabaghi, D. Weiss (Tübingen, Germany)

    Objective: In this work, we aimed to characterize the differential effect of subthalamic nucleus (STN) or substantia nigra pars reticulata (SNr) stimulation on kinematic gait…
  • 2017 International Congress

    Electrode Impedance as a marker for “on” and “off” states in a Deep Brain Stimulation cohort: A pilot study

    W. Deeb, J. Shute, M. Okun (Gainesville, FL, USA)

    Objective: To determine the possible use of electrical impedance as an easily measured surrogate measure for clinical changes in patients with Parkinson’s disease (PD) with…
  • 2017 International Congress

    Meta-analysis of mortality following Subthalamic and Pallidal deep brain stimulation for patients with Parkinson’s disease

    A. Negida (Zagazig, El-Sharkia, Egypt)

    Objective: The aim of this meta-analysis is to compare mortality after subthalamic (STN) and pallidal (GPi) deep brain stimulation (DBS) for patients with Parkinson's disease…
  • 2017 International Congress

    Battery consumption and need for replacement in patients with Parkinson disease treated with interleaved deep brain stimulation

    L. Deuel, J. Pilitsis, A. Ramirez-Zamora (Albany, NY, USA)

    Objective: To evaluate battery life in patients managed with unilateral or bilateral subthalamic nucleus (STN) interleaved deep brain stimulation (DBS) Background: DBS is a common…
  • 2017 International Congress

    Clinical utility of chronic directional subthalamic Deep Brain Stimulatoin in Parkinson’s Disease

    C. Hartmann, L. Venkatesan, P. Slotty, J. Vesper, A. Schnitzler (Düsseldorf, Germany)

    Objective: Here, we present our 3-month clinical experience with subthalamic directional DBS in treating Parkinson’s disease (PD) symptoms. Background: Directional Deep Brain Stimulation (DBS) is…
  • 2017 International Congress

    GammaKnife subthalamotomy for Parkinson’s disease

    t. witjas, r. carron, a. eusebio, j.p. azulay, j. regis (marseille, France)

    Objective: To assess the feasibility of GammaKnife subthalamotomy in Parkinson's disease Background: Chronic STN stimulation is an established treatment for complicated PD. Bilateral subthalamotomy may…
  • 2017 International Congress

    The non-motor symptoms in Parkinsons’s disease patients treated with STN DBS: the follow up study

    M. Mencinger, M. Červek, T. Rus, G. Jakob, D. Georgiev, D. Flisar, R. Rajnar, M. Benedičič, K. Boetzel, J. Mehrkens, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: The aim of the study was to follow-up the effect of STN DBS on motor and non-motor symptoms in aPD.  Background: A comprehensive assessment…
  • 2017 International Congress

    UPDRS III score and RS latency can determine the possible neuromodulative role of STN DBS in Parkinson’s disease (PD) patients

    S. Szlufik, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of this study was to evaluate the impact of STN DBS on the changes of UPDRS scale and RS parameters (OFF phase)…
  • « Previous Page
  • 1
  • …
  • 1409
  • 1410
  • 1411
  • 1412
  • 1413
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley